A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function

被引：158

作者：

Ozer, Josef S. ^{[1
]}

Dieterle, Frank ^{[2
]}

Troth, Sean ^{[3
]}

Perentes, Elias ^{[2
]}

Cordier, Andre ^{[2
]}

Verdes, Pablo ^{[2
]}

Staedtler, Frank ^{[2
]}

Mahl, Andreas ^{[2
]}

Grenet, Olivier ^{[2
]}

Roth, Daniel R. ^{[2
]}

Wahl, Daniel ^{[2
]}

Legay, Francois ^{[2
]}

Holder, Daniel ^{[4
]}

Erdos, Zoltan ^{[1
]}

Vlasakova, Katerina ^{[1
]}

Jin, Hong ^{[1
]}

Yu, Yan ^{[1
]}

Muniappa, Nagaraja ^{[3
]}

Forest, Tom ^{[1
]}

Clouse, Holly K. ^{[5
]}

Reynolds, Spencer ^{[1
]}

Bailey, Wendy J. ^{[1
]}

Thudium, Douglas T. ^{[1
]}

Topper, Michael J. ^{[1
]}

Skopek, Thomas R. ^{[1
]}

Sina, Joseph F. ^{[1
]}

Glaab, Warren E. ^{[1
]}

Vonderscher, Jacky ^{[2
]}

Maurer, Gerard ^{[2
]}

Chibout, Salah-Dine ^{[2
]}

Sistare, Frank D. ^{[1
]}

Gerhold, David L. ^{[1
]}

机构：

[1] Merck Res Labs, Dept Investigat Lab Sci, West Point, PA USA

[2] Novartis Inst BioMed Res, Basel, Switzerland

[3] Merck Res Labs, Dept Pathol, West Point, PA USA

[4] Merck Res Labs, Dept Biometr, West Point, PA USA

[5] Merck Res Labs, Dept Exploratory Toxicol, West Point, PA USA

来源：

NATURE BIOTECHNOLOGY | 2010年 / 28卷 / 05期

关键词：

CYSTATIN-C; KIDNEY INJURY; MOLECULE-1; CLUSTERIN; PROTEIN;

D O I：

10.1038/nbt.1627

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The Predictive Safety Testing Consortium's first regulatory submission to qualify kidney safety biomarkers revealed two deficiencies. To address the need for biomarkers that monitor recovery from agent-induced renal damage, we scored changes in the levels of urinary biomarkers in rats during recovery from renal injury induced by exposure to carbapenem A or gentamicin. All biomarkers responded to histologic tubular toxicities to varied degrees and with different kinetics. After a recovery period, all biomarkers returned to levels approaching those observed in uninjured animals. We next addressed the need for a serum biomarker that reflects general kidney function regardless of the exact site of renal injury. Our assay for serum cystatin C is more sensitive and specific than serum creatinine (SCr) or blood urea nitrogen (BUN) in monitoring generalized renal function after exposure of rats to eight nephrotoxicants and two hepatotoxicants. This sensitive serum biomarker will enable testing of renal function in animal studies that do not involve urine collection.

引用

页码：486 / U146

页数：11

共 29 条

[11] TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution [J].

Hoffmann, W .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (24) :2932-2938

[12] Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury [J].

Ichimura, T ;

Hung, CC ;

Yang, SA ;

Stevens, JL ;

Bonventre, JV .

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 286 (03) :F552-F563

[13] Serum cystatin C as a marker of glomerular filtration rate [J].

Madero, Magdalena ;

Sarnak, Mark J. ;

Stevens, Lesley A. .

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2006, 15 (06) :610-616

[14] Translational Toxicology and the Work of the Predictive Safety Testing Consortium [J].

Mattes, W. B. ;

Walker, E. G. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (03) :327-330

[15] Biochemistry and clinical role of human cystatin C [J].

Mussap, M ;

Plebani, M .

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2004, 41 (5-6) :467-550

[16] Modulation of clusterin Isoforms is associated with all-trans retinoic acid-induced proliferative arrest and apoptosis of intimal smooth muscle cells [J].

Orlandi, A ;

Pucci, S ;

Ciucci, A ;

Pichiorri, F ;

Ferlosio, A ;

Spagnoli, LG .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (02) :348-353

[17] Cellular and molecular events leading to renal tubulointerstitial fibrosis [J].

Razzaque M.S. ;

Taguchi T. .

Medical Electron Microscopy, 2002, 35 (2) :68-80

[18] Reduced immunotoxicity and preservation of antibacterial activity in a releasable side-chain carbapenem antibiotic [J].

Rosen, H ;

Hajdu, R ;

Silver, L ;

Kropp, H ;

Dorso, K ;

Kohler, J ;

Sundelof, JG ;

Huber, J ;

Hammond, GG ;

Jackson, JJ ;

Gill, CJ ;

Thompson, R ;

Pelak, BA ;

Epstein-Toney, JH ;

Lankas, G ;

Wilkening, RR ;

Wildonger, KJ ;

Blizzard, TA ;

DiNinno, FP ;

Ratcliffe, RW ;

Heck, JV ;

Kozarich, JW ;

Hammond, ML .

SCIENCE, 1999, 283 (5402) :703-706

[19] Update on cystatin C: new insights into the importance of mild kidney dysfunction [J].

Shlipak, Michael G. ;

Praught, Melanie L. ;

Sarnak, Mark J. .

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2006, 15 (03) :270-275

[20]

Silkensen JR, 1997, J AM SOC NEPHROL, V8, P302

← 1 2 3 →